Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisJulian D. Gillmore, Philip N. Hawkins, Helen J. Lachmann et al.|Circulation|2016Cited by 2k
A new staging system for cardiac transthyretin amyloidosisJulian D. Gillmore, Philip N. Hawkins, Thibaud Damy et al.|European Heart Journal|2017Cited by 740
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving mythsEsther González-López, Pablo García‐Pavía, Christian Gagliardi et al.|European Heart Journal|2017Cited by 373
Prevalence, Characteristics and Outcomes of Older Patients with Hereditary Versus Wild-Type Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Julian D. Gillmore, Yousuf Razvi et al.|European Journal of Heart Failure|2023Cited by 97
Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosisLiza Chacko, Marianna Fontana, Nina Karia et al.|European Journal of Heart Failure|2022Cited by 83